Drawing for NOURICEL-MD PATENTED. PURE.

USPTO serial 76207803

NOURICEL-MD PATENTED. PURE.

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DALIER, LAURIEL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NOURICEL-MD PATENTED. PURE.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia Anne Matheson

FINNEGAN, HENDERSON, FARABOW GARRET & DUNNER LLP1300 I ST NWWASHINGTON, DC 20005-3314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical additives for use in the manufacture of cosmetic creams and lotions, namely, creams and lotions to diminish wrinkles and rejuvenate the appearance of the skin; chemical additives for use in the manufacture of topical agents, wound care and skin regeneration products; and chemical additives for use in the manufacture of hair, scalp, nail, and cuticle care products; chemicals for use as a conditioned medium for stimulating cell growth and metabolism for scientific or medical research purposesACTIVE—
003Cosmetic creams and lotions; hair care preparations, scalp preparations, nail and cuticle creams; cuticle removing preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 2, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 2, 2003DOCKASSIGNED TO EXAMINER—
May 17, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 17, 2002DOCKASSIGNED TO EXAMINER—
Mar 14, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2002DOCKASSIGNED TO EXAMINER—
Jan 30, 2002DOCKASSIGNED TO EXAMINER—
Dec 6, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance